Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients

NCT03650894 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasm Female
Breast Cancer
Breast Carcinoma
Breast Tumor

Interventions

DRUG: Nivolumab
DRUG: Ipilimumab
DRUG: Bicalutamide

Sponsor

Providence Health & Services

Collaborators

[object Object]
[object Object]